PEDIATRICS Vol. 108 No. 5 November 2001, pp. 1180-1186

Unexplained Reduced Microbiological Efficacy of Intramuscular Benzathine Penicillin G and of Oral Penicillin V in Eradication of Group A Streptococci From Children With Acute Pharyngitis

Received Feb 28, 2001; accepted Jun 14, 2001.

From the Department of Pediatrics and the World Health Organization Collaborating Center for Reference and Research on Streptococci, University of Minnesota Medical School, Minneapolis, Minnesota.

Objective.  To evaluate the efficacy of oral penicillin V and intramuscular benzathine penicillin G (BPG) in eradicating group A streptococci from the upper respiratory tract.

Methodology.  Two randomized, single-blind, multicenter antibiotic efficacy trials in children using recommended doses of either oral penicillin V or intramuscular BPG for treatment of acute-onset pharyngitis associated with isolation of group A streptococci were conducted. Throat examinations and cultures were obtained at enrollment and on days 5 to 8, 10 to 14, and 29 to 31.

Results.  Thirty-five percent of 284 evaluable patients treated with oral penicillin V and 37% of BPG-treated patients were microbiologic treatment failures at either 10 to 14 or 29 to 31 days.

Conclusions.  Although these findings do not provide sufficient evidence to change current treatment recommendations or public health policy, important questions are raised about currently recommended penicillin doses, about the role of the carrier state, and possibly about adequate bioavailability of intramuscular BPG. These findings require confirmation.  Key words:  benzathine penicillin G, penicillin V, ceftriaxone, streptococcal pharyngitis, streptococcal carrier.

CiteULike    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. R. Casey and M. E. Pichichero Symptomatic Relapse of Group A {beta}-Hemolytic Streptococcal Tonsillopharyngitis in Children Clinical Pediatrics, May 1, 2007; 46(4): 307 - 310. [Abstract] [PDF]

				M. E. Pichichero The Importance of Bacteriologic Eradication in the Treatment of Group A Streptococcal Tonsillopharyngitis Clinical Pediatrics, May 1, 2007; 46(4_suppl): 3S - 16S. [Abstract] [PDF]

				I. Brook Penicillin Failure in the Treatment of Acute and Relapsing Tonsillopharyngitis Is Associated With Copathogens and Alteration of Microbial Balance: A Role for Cephalosporins Clinical Pediatrics, May 1, 2007; 46(4_suppl): 17S - 24S. [Abstract] [PDF]

				J. R. Casey Selecting the Optimal Antibiotic in the Treatment of Group A {beta}-Hemolytic Streptococci Pharyngitis Clinical Pediatrics, May 1, 2007; 46(4_suppl): 25S - 35S. [Abstract] [PDF]

				S. M. Marcy Treatment Options for Streptococcal Pharyngitis Clinical Pediatrics, May 1, 2007; 46(4_suppl): 36S - 45S. [Abstract] [PDF]

				M. A. Chaussee, E. J. McDowell, L. D. Rieck, E. A. Callegari, and M. S. Chaussee Proteomic analysis of a penicillin-tolerant rgg mutant strain of Streptococcus pyogenes J. Antimicrob. Chemother., October 1, 2006; 58(4): 752 - 759. [Abstract] [Full Text] [PDF]

				D. A. Robinson, J. A. Sutcliffe, W. Tewodros, A. Manoharan, and D. E. Bessen Evolution and global dissemination of macrolide-resistant group a streptococci. Antimicrob. Agents Chemother., September 1, 2006; 50(9): 2903 - 2911. [Abstract] [Full Text] [PDF]

				B. Wang, S. Li, P. J. Southern, and P. P. Cleary Streptococcal modulation of cellular invasion via TGF-beta1 signaling PNAS, February 14, 2006; 103(7): 2380 - 2385. [Abstract] [Full Text] [PDF]

				H.-S. Park and P. P. Cleary Active and Passive Intranasal Immunizations with Streptococcal Surface Protein C5a Peptidase Prevent Infection of Murine Nasal Mucosa-Associated Lymphoid Tissue, a Functional Homologue of Human Tonsils Infect. Immun., December 1, 2005; 73(12): 7878 - 7886. [Abstract] [Full Text] [PDF]

				J. L. Blumer, M. D. Reed, E. L. Kaplan, and G. L. Drusano Explaining the Poor Bacteriologic Eradication Rate of Single-Dose Ceftriaxone in Group A Streptococcal Tonsillopharyngitis: A Reverse Engineering Solution Using Pharmacodynamic Modeling Pediatrics, October 1, 2005; 116(4): 927 - 932. [Abstract] [Full Text] [PDF]

				S. Esposito, F. Blasi, S. Bosis, R. Droghetti, N. Faelli, A. Lastrico, and N. Principi Aetiology of acute pharyngitis: the role of atypical bacteria J. Med. Microbiol., July 1, 2004; 53(7): 645 - 651. [Abstract] [Full Text] [PDF]

				J. R. Casey and M. E. Pichichero Meta-analysis of Cephalosporin Versus Penicillin Treatment of Group A Streptococcal Tonsillopharyngitis in Children Pediatrics, April 1, 2004; 113(4): 866 - 882. [Abstract] [Full Text] [PDF]

				S. L. Block Short-Course Antimicrobial Therapy of Streptococcal Pharyngitis Clinical Pediatrics, October 1, 2003; 42(8): 663 - 671. [PDF]

eLetters: